AUS
NZ
UK
CA
USA
IND
Healthcare
How Is ImmunoPrecise Antibodies Advancing Research on Aging?
October 28, 2024 05:37 AM PDT| By Team Kalkine MediaHighlights,ImmunoPrecise Antibodies,(NASDAQ:IPA),contributes to a significant study on mitochondrial dysfunction.,The research aims to enhance understanding of age-related diseases such as Parkinson's and Alzheimer's.,The company is well-positioned t...
Evoke Pharma Gains Momentum with GIMOTI Study Success
October 28, 2024 05:34 AM PDT| By Team Kalkine MediaHighlights,Evoke Pharma,(NASDAQ:EVOK),reports positive patient outcomes with GIMOTI nasal spray for diabetic gastroparesis.,A real-world study shows significant reductions in healthcare visits for GIMOTI users.,Recognition at ACG 2024 highlights the...
How Will FDA Approval Boost Iterum Therapeutics Stock?
October 28, 2024 05:17 AM PDT| By Team Kalkine MediaHighlights,Iterum Therapeutics announces a conference call to discuss FDA approval of ORLYNVAH.,The treatment marks a significant milestone as the first oral penem approved in the U.S.,ORLYNVAHis aimed at addressing uncomplicated urinary tract infect...
Signaturefd LLC Associated with Growth in Exelixis, Inc. Stake
October 28, 2024 04:31 AM PDT| By Team Kalkine MediaHighlights,Signaturefd LLC increased its holdings in Exelixis, Inc. by 12.2% in the third quarter, reflecting growing confidence in the biotechnology sector.,Institutional ownership of Exelixis remains robust, with 85.27% of shares held by large inve...
Pfizer Management's Turnaround Strategy Being Enhanced Amid Starboard's Watch
October 28, 2024 04:21 AM PDT| By Team Kalkine MediaHighlights,Pfizer's upcoming quarterly financial report is under scrutiny as activist hedge fund Starboard Value intensifies calls for accountability and results.,Analysts seek evidence of improved profitability and revenue growth, particularly from...
Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT) Announces Encouraging Data for VOQUEZNA® at ACG 2024
October 28, 2024 03:49 AM PDT| By Team Kalkine MediaHighlights:,VOQUEZNA® shows rapid relief for heartburn in Non-Erosive GERD.,ACG Outstanding Research Award recognizes significant findings from the PHALCON-NERD-201 trial.,On-demand dosing could revolutionize treatment options for patients with episo...
IDEAYA Biosciences, Inc. (Nasdaq:IDYA) Advances with IND Clearance for IDE275, a Promising Werner Helicase Inhibitor
October 28, 2024 03:22 AM PDT| By Team Kalkine MediaHighlights:,IDEAYA's IDE275 could become a first-in-class treatment for tumors with microsatellite instability.,The Phase 1 trial aims to target a significant patient population across several cancer types.,Potential for substantial financial milesto...
How Did Dexcom Beat Expectations Despite Revenue Challenges?
October 25, 2024 11:43 AM PDT| By Team Kalkine MediaHighlights,Dexcom reports a decline in U.S. revenue despite strong third-quarter results.,The healthcare sector company maintains its full-year revenue guidance amidst market performance.,Changes in Dexcom’s leadership announced, impacting its commer...
What Is Iterum Therapeutics' Latest FDA Approval About?
October 25, 2024 11:34 AM PDT| By Team Kalkine MediaHighlights,Iterum Therapeutics receives FDA approval for its new drug, ORLYNVAH.,ORLYNVAH targets uncomplicated urinary tract infections in adult women.,The approval marks Iterum’s first FDA-approved product.,Iterum Therapeutics plc, a pharmaceutical...
Tectonic Advisors LLC Secures 9,958 Shares in Gilead Sciences, Inc. (NASDAQ:GILD)
October 25, 2024 04:45 AM PDT| By Team Kalkine MediaHighlights,Tectonic Advisors LLC increased its position in Gilead Sciences, Inc. by 15.1% during the third quarter.,Institutional ownership of Gilead has reached 83.67%, with several firms making notable adjustments to their stakes.,Analysts have rai...
Shareholders in Bio-Rad Laboratories (NYSE:BIO) Experience 58% Decline as Shares Fall 4.6% This Week
October 25, 2024 04:10 AM PDT| By Team Kalkine MediaHighlights,Bio-Rad Laboratories, Inc. has experienced a significant decline in share price, dropping 58% over the past three years.,Recent financial performance indicates a loss over the last twelve months, raising concerns about future profitability...
Position in Natera, Inc. (NASDAQ:NTRA) Strengthened by Zweig DiMenna Associates LLC
October 25, 2024 04:01 AM PDT| By Team Kalkine MediaHighlights,Zweig DiMenna Associates LLC significantly increased its stake in Natera, Inc. by 213% during the third quarter.,Natera's recent earnings report exceeded consensus estimates, showcasing robust revenue growth.,Several analysts have raised t...
Boston Scientific's Strong Performance: A Positive Outlook Ahead
October 24, 2024 10:26 PM PDT| By Team Kalkine MediaHeadlines,Boston Scientific delivers impressive quarterly earnings, surpassing expectations.,Analysts provide optimistic outlooks, adjusting price targets upward.,Strong financial metrics highlight the company's growth potential.,Boston Scientific,(N...
Why Did Zynex Receive FDA Clearance for Its New Device?
October 24, 2024 03:12 PM PDT| By Team Kalkine MediaHighlights,Zynex Inc. reports an increase in orders for its pain management devices.,The company secures FDA clearance for its new TensWave device.,Zynex aims to diversify revenue through orthopedic products and expand its salesforce.,Zynex Inc., a k...
Why Did Merck’s KEYTRUDA Secure Two New EU Approvals?
October 24, 2024 02:11 PM PDT| By Team Kalkine MediaHighlights,Merck gains two new EU approvals for KEYTRUDA in gynecologic cancers.,Approvals cover treatments for advanced endometrial and cervical cancers.,Clinical trials show significant benefits in disease progression and survival.,Merck, a leading...
Strong Earnings Propel Laboratory Co. of America Stock Higher
October 24, 2024 12:43 PM PDT| By Team Kalkine MediaHeadlines,Laboratory Co. of America experiences significant stock increase,Strong earnings exceed expectations, boosting market confidence,Upcoming dividend highlights commitment to shareholder returns,Laboratory Co. of America Holdings,(NYSE:LH),wit...
Riverwater Partners LLC Expands Ownership in Haemonetics Co. (NYSE:HAE)
October 24, 2024 04:27 AM PDT| By Team Kalkine MediaHighlights,Significant Increase in Holdings: Riverwater Partners LLC raised its stake in Haemonetics Co. by 185% in Q3 2024, acquiring over 29,000 additional shares.,Institutional Activity: Other institutional investors also adjusted their positions,...
What Is Driving Sangamo Therapeutics' Recent Momentum?
October 23, 2024 12:35 PM PDT| By Team Kalkine MediaHighlights,Sangamo Therapeutics experiences significant momentum in share price within the biotech sector.,Despite recent gains, the company faces concerns over its price-to-sales ratio compared to industry norms.,Revenue trends reveal challenges, bu...
How Is OKYO Pharma Addressing the Unmet Need for NCP Treatment?
October 23, 2024 12:20 PM PDT| By Team Kalkine MediaHighlights,OKYO Pharma Ltd begins Phase 2 trial of OK-101 for neuropathic corneal pain (NCP).,The trial targets a chronic condition currently lacking FDA-approved treatments.,The study involves a randomized, placebo-controlled format to evaluate safe...
Pfizer (PFE) Gains Strong Attention with New Rating from Cantor Fitzgerald
October 23, 2024 11:41 AM PDT| By Team Kalkine MediaHeadlines,Pfizer receives positive recognition from Cantor Fitzgerald.,Multiple research firms adjust their outlook on Pfizer.,Analysts maintain favorable outlook for Pfizer’s future.,Pfizer,(NYSE:PFE),has earned renewed attention after Cantor Fitzge...
